Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease
Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease.
Cimzia (certolizumab pegol) is a tumor necrosis factor blocker... similar to Humira (adalimumab) and Remicade (infliximab).
Cimzia is "PEGylated" to extend its half-life. It can be given every 4 weeks...instead of every 2 weeks like Humira.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote